NCT02044354View on ClinicalTrials.gov

Patient Preference Between Cabazitaxel and Docetaxel in Metastatic Castrate-resistant Prostate Cancer

PHASE3UnknownINTERVENTIONAL
Enrollment

195

Participants

Timeline

Start Date

May 22, 2014

Primary Completion Date

April 13, 2017

Study Completion Date

April 30, 2018

Conditions
Metastatic Castration-resistant Prostate Cancer
Interventions
DRUG

Taxotere

DRUG

Jevtana

Trial Locations (1)

94805

Gustave Roussy, Villejuif

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Gustave Roussy, Cancer Campus, Grand Paris

OTHER